135 related articles for article (PubMed ID: 8049143)
1. Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cells.
Berg JP; Liane KM; Bjørhovde SB; Bjøro T; Torjesen PA; Haug E
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):145-50. PubMed ID: 8049143
[TBL] [Abstract][Full Text] [Related]
2. 1,25-dihydroxyvitamin D3 attenuates TSH and 8-(4-chlorophenylthio)-cAMP-stimulated growth and iodide uptake by rat thyroid cells (FRTL-5).
Berg JP; Torjesen PA; Haug E
Thyroid; 1993; 3(3):245-51. PubMed ID: 8257867
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxycholecalciferol attenuates thyrotropin stimulated iodide accumulation in rat thyroid follicular FRTL-5 cells by reducing iodide porter number.
Lamberg-Allardt C; Valtonen E
Biochem Biophys Res Commun; 1992 Feb; 182(3):1435-9. PubMed ID: 1311573
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells. Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake.
Lamberg-Allardt C; Valtonen E; Polojärvi M; Stewen P
Mol Cell Endocrinol; 1991 Oct; 81(1-3):25-31. PubMed ID: 1665829
[TBL] [Abstract][Full Text] [Related]
5. Cholecalciferol metabolites attenuate cAMP production in rat thyroid cells (FRTL-5).
Berg JP; Sørnes G; Torjesen PA; Haug E
Mol Cell Endocrinol; 1991 Apr; 76(1-3):201-6. PubMed ID: 1668203
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydrocortisone on the ability of thyrotropin to increase deoxyribonucleic acid synthesis and iodide uptake in FRTL-5 rat thyroid cells: opposite regulation of adenosine 3',5'-monophosphate signal action.
Saji M; Kohn LD
Endocrinology; 1990 Oct; 127(4):1867-76. PubMed ID: 2169405
[TBL] [Abstract][Full Text] [Related]
7. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha.
Berg JP; Sandvik JA; Ree AH; Sørnes G; Bjøro T; Torjesen PA; Gordeladze JO; Haug E
Endocrinology; 1994 Aug; 135(2):595-602. PubMed ID: 8033808
[TBL] [Abstract][Full Text] [Related]
9. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
10. Insulin and insulin-like growth factor-I inhibit thyrotropin-increased iodide transport in serum-depleted FRTL-5 rat thyroid cells: modulation of adenosine 3',5'-monophosphate signal action.
Saji M; Kohn LD
Endocrinology; 1991 Feb; 128(2):1136-43. PubMed ID: 1846578
[TBL] [Abstract][Full Text] [Related]
11. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
12. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
13. The interaction of signal transduction pathways in FRTL5 thyroid follicular cells: studies with stable expression of beta 2-adrenergic receptors.
Tsuzaki S; Cone RD; Frazier AL; Moses AC
Endocrinology; 1991 Mar; 128(3):1359-68. PubMed ID: 1847855
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK
Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
[TBL] [Abstract][Full Text] [Related]
15. A sensitive thyrotropin (TSH) bioassay based on iodide uptake in rat FRTL-5 thyroid cells: comparison with the adenosine 3',5'-monophosphate response to human serum TSH and enzymatically deglycosylated bovine and human TSH.
Nissim M; Lee KO; Petrick PA; Dahlberg PA; Weintraub BD
Endocrinology; 1987 Oct; 121(4):1278-87. PubMed ID: 2820695
[TBL] [Abstract][Full Text] [Related]
16. The effects of lysophosphatidate on thyrotropin-mediated differentiated thyroid function in FRTL-5 thyroid cells.
Das S; Devlin M; Brindley DN; Ginsberg J
Thyroid; 1999 Jun; 9(6):621-6. PubMed ID: 10411126
[TBL] [Abstract][Full Text] [Related]
17. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
[TBL] [Abstract][Full Text] [Related]
18. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF
J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
20. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
